Ежедневный обзор рынка от GT Capital | Аналитические обзоры

[gtcapital]

В этой ветке каждое утро компания GT Capital Group будет публиковать свой обзор рынка США.

Компания GT Capital Group образована группой профессиональных трейдеров.
Цель
Наша миссия принести в сообщество русских трейдеров профессионализм и высокое качество услуг. Мы внимательно ознакомились с проблемами, существующими в России в этой сфере и изначально приняли меры по организации бизнеса, опережающие существующие общепринятые системы на несколько лет. Этот подход – на опережение – отражен, как и в оказании сервиса по торговле ценными бумагами, так и в профессиональном обучении на основе американских стандартов.
Описание
Дейтрейдинг на американских фондовых биржах: NYSE, NASDAQ, AMEX. Проп-торговля, обучение, аналитика и дополнительные сервисы для трейдеров. Депозит - от $500.

С наилучшими пожеланиями,
Команда GT Capital Group
http://gtstocks.com
info@gtstocks.com

[gtcapital]

Фьючерсы на индексы растут

Ближайший уровень поддержки по SPY – 200.60 уровень сопротивления – 201.20



MNK продолжает расти выше на премаркете

GD покупка выше 125

RPRX покупка от 18

Gapping up/down: ITI +11% and PVH +8% after earnings, BOLT +36% on merger with TDY, MITK +69% on litigation settlement; CIEN -10%, SCVL -9% and JOY -2% after earnings, GPRO -3.7% after dg

Gapping up
In reaction to strong earnings/guidance/SSS: ITI +11.2%, MEI +10.9%, MAGS +9.9%, PVH +8.4%, BV +5.6%, DDC +4.9%, ABM +3.3%, PAY +2.5%, HRB +2%, COST +1.4%, MBLY +1%

M&A news: BOLT +36.6% (to be acquired by Teledyne (TDY) for $22 per share in cash), BWP +2.7% (to acquire Evangeline ethylene pipeline system for $295 mln in cash), SYNL +1.1% (announces sale of Ram-Fab in Crossett, Arkansas to a subsidiary of Primoris Services (PRIM)).

Other news: MITK +68.8% (announced settlement of pending litigation with USAA), SGOC +16.2% (seeing continued strength following yesterday's 50% move higher), TIBX +7.6% (announced a review of strategic alternatives), HMSY +5.3% (modestly rebounding in premkt trade), MHGC +5.1% (announced its special transaction committee has directed Morgan Stanley to reach out to possible counterparties regarding their interest in potential transactions), TASR +3.8% (announces multiple orders of its TASER brand next generation Smart Weapons, aslo positive Mad Money mention), ISNS +3.7% (pulling back following recent gains), NLNK +2.7% (FDA gives NewLink Genetics approval to proceed to phase 1 clinical studies of their ebola vaccine), MPET +2.5% (announces drilling operations on the Horse Hill-1 well commenced on Sep 3, 2014), ALLT +2.2% (announces follow-on order with a Tier-1 global telecommunications group), ECR +2.1% (announced the commencement of production at two of the Co's pad locations consisting of a total of 7 Utica Shale wells; co also reaffirmed its production guidance for Q3), PLUG +1.3% (announces Chris Hutter has been appointed CFO), CELG +0.9% (reported Phase III FIRST trial of REVLIMID Plus Dexamethasone)

Analyst comments: OI +2.2% (initiated with an Outperform at BMO Capital Mkts), DHI +2% (upgraded to Buy from Neutral at UBS), CERN +1.4% (resumed with a Overweight at JP Morgan), HIMX +1.3% (tgt raise at Brean Cap'l), IACI +1.2% (upgraded to Overweight from Equal Weight at Barclays), LPX +1.1% (initiated with an Outperform at BMO Capital Mkts), INFI +1.1% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities), FL +0.6% (initiated with a Buy at Jefferies), COP +0.6% (target raised to $95), PKG +0.5% (initiated with an Outperform at BMO Capital Mkts)

Gapping down
In reaction to disappointing earnings/guidance: MTRX -15.9%, CIEN -10%, SCVL -8.7%, AVAV -6.4%, JOY -2.3%, UTIW -1%

Other news: KMDA -19.3% (eports final results from Phase 2/3 clinical trial of inhaled Alpha-1 Antitrypsin to treat Alpha-1 Antitrypsin deficiency), GNE -8.8% (stated it is considering alternative ways forward for oil shale pilot project in Israel following the Jerusalem District Committee for Planning and Building vote to decline to issue a permit to build and operate an oil shale pilot drilling project), SMLP -4.9% (announced public offering of 4 mln common units by selling unitholders), MEMP -4.8% (announced public offering of 13 mln common units), AI -3.5% (announced offering of 2.75 mln shares of common stock), YUM -3.2% (disclosed significant, negative impact to sales at both KFC and Pizza Hut in China; sees Q3 same store sales -13%), NRF -2.6% (announced public offering of 45 mln shares with a forward component), GRUB -1.4% (prices follow-on public offering of 10,468,198 shares of common stock offered by the co and certain stockholders at $40.25 per share), DEPO -0.6% (announces pricing of upsized $300 mln convertible Senior Notes due 2021)

Analyst comments: TNGO -4.1% (downgraded to Equal Weight from Overweight at Barclays), GPRO -3.7% (downgraded to Neutral from Overweight at JP Morgan), DDD -2.5% (downgraded to Sector Perform from Outperform at Pacific Crest), INFA -1% (downgraded to Equal Weight from Overweight at Barclays), LVS -0.5% (downgraded to Hold from Buy at Argus)

Оригинал статьи: gtstocks.com/analytics-04-09-2014.html

[gtcapital]

SPY упал на премаркете

Ближайший уровень поддержки по SPY – 199.50 уровень сопротивления – 200.30



COST покупка при ужержании 125

EMES покупка выше 125

EGN смотрим на разворот

Gapping up/down: BLOX +13% and AMBA +9% after earnings, PRAN +28% after orphan designation status, CIEN +2% after upgrade; GPX -6% and FNSR -5% after earnings/SSS, KORS -5% after offering

Gapping up
In reaction to strong earnings/guidance: BLOX +13.4%, AMBA +9.3%, LOCO +2.9%, VRNT +2.6%.

Other news: PRAN +27.6% (received orphan designation status for its product for the treatment of Huntington's disease), HART +13.7% (received orphan designation status for its inBreath airway transplant system to restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection), NSPH +10.8% (has engaged Jefferies LLC as its financial advisor to assist it in the development and evaluation of a full range of potential strategic alternatives for the Company), TASR +6% (higher following announcement that the NYPD will begin a pilot program of equipping officers with body cameras), OMED +4.1% (FDA removes partial clinical hold on OncoMed's ipafricept), ICLD +2.8% (announces multi-site deployment of security and threat prevention solutions and services for a large global consulting firm), MOBI +2.6% (announces repurchase of 16 mln shares from Sequoia Capital ), GPRO +1.7% (up in sympathy following supplier AMBA earnings), DGLY +1.5% (cont usual volatility pre-mkt), JOY +1% (positive Barron's mention), SD +0.8% ( announces $200 mln share repurchase program)

Analyst comments: IPCI +3.7% (upgraded to Buy at Maxim Group), VRTX +2.3% (upgraded to Buy from Neutral at Goldman), CIEN +1.8% (upgraded to Buy from Neutral at Goldman), ICPT +1.8% (initiated with an Outperform at Cowen), MTRX +1.7% (upgraded to Overweight from Equal Weight at First Analysis Sec), SNDK +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley), BLUE +1.4% (initiated with a Buy at Sun Trust Rbsn Humphrey), INSM +1.4% (initiated with an Outperform at Cowen), MBLY +1.4% (target raised to $52 at RBC Capital Mkts), IL +1.1% (upgraded to Buy at Stifel ), ING +1% (upgraded to Overweight from Equal Weight at Barclays), BEAV +1% (upgraded to Buy from Hold at Deutsche Bank), BP +0.9% (upgraded to Buy from Neutral at Citigroup), QGEN +0.6% (upgraded to Buy from Sell at DZ Bank)

Gapping down
In reaction to disappointing earnings/guidance: ZQK -12.4%, GPS -5.8%, ZUMZ -5.1%, FNSR -5%, SEAC -4.3%, BEBE -2.8%, BEBE -2.8%, COO -2.1%.

Other news: REPH -40.5% (announced that the Phase 2b clinical trial of Dex-IN for the treatmnet of acute post-operative pain is not expected to reach statistical significance at its current design), KORS -5.1% (Michael Kors files for ordinary share shelf offering by selling shareholders; launches secondary public offering of ordinary shares on behalf of Sportswear, one of its principal founding shareholders, for the offering of 11,629,627 ordinary shares), TUMI -4.4% (announced secondary offering of 8 mln shares of common stock by Doughty Hanson & Co. Managers Limited), PNNT -4% ( announces public offering of 11 mln shares of common stock), GLNG -3.5% (announces secondary offering of ~27.83 mln shares of its common stock by World Shipholding Ltd.), HMY -2.5% (still checking), ST -2.2% (announced offering of ~15.05 mln ordinary shares by selling shareholders), CX -2% (prices of €400 mln and $1.1 bln in Senior Secured Notes), SDRL -1.7% (still checking), AU -1.6% (still checking), GSK -1.5% (will not be able to fill all demand for flu vaccines, according to reports), GTAT -1.3% (cont vol due to speculation surrounding iPhone component), SHPG -1% (still checking).

Analyst comments: TTWO -1.3% (downgraded to Neutral from Buy at Sterne Agee), CS -1.1% (downgraded to Neutral from Buy at UBS), PCLN -0.7% (downgraded to Equal Weight from Overweight at Evercore ), MS -0.7% (downgraded to Neutral from Outperform at Macquarie).

Оригинал статьи: gtstocks.com/analytics-05-09-2014.html

[gtcapital]

SPY на премаркете стоит в узком коридоре после гэпа вниз

Ближайший уровень поддержки по SPY – 200.80 уровень сопротивления – 201.00



DATA смотрим на продажу ниже 70

SPLK продажа ниже 59.50

NKE смотрим на продолжение роста

COST смотрим на покупку выше 127

NXPI покупка выше 71

Gapping up/down: MGAM +28% following merger with GCA, RAX +5% on M&A reports, FEYE +3% after upgrade; CPB -3% after earnings, UK stocks under pressure, F-2% after dg

Gapping up
In reaction to strong earnings/guidance: XCRA +2.1%

M&A news: MGAM +28.7% (to be acquired by Global Cash Access (GCA) for $36.50/share in cash), RAX +4.7% (CenturyLink (CTL) considering acquisition of RAX, according to reports)

Other news: MSTX +11.1% (announces positive top line results from Phase 2 study of AIR001), ISNS +7.3% (co and NuPark LLC announced that they have completed an integration and partnership agreement), ASTI +6.8% (files for 1 mln share common stock offering by selling shareholders), ALLT +5.1% (receives an expansion order of $15 mln from a Tier-1 Operator), HTZ +3.3% (announces Mark Frissora to step down as Chairman and CEO), BCRX +3.1% (announces RAPIVAB trial results for the treatment of influenza), YHOO +2.9% (rising in advance of BABA IPO release, also positive commentary on Mad Money), GLUU +2.7% (discloses it extended its licensing agreement with Kim Kardashian by three years), HIMX +1.9% (Google Glass on sale in GOOG Play store), NVAX +1.7% (presents data on RSV F Nanoparticle vaccine induced monoclonal antibody), GTAT +1.1% (Former GTAT employee Paul Matthews claims that GTAT sapphire covers are in AAPL iPhone 6, according to reports), SYN +1.1% (highlights SYN-005 data; SYN-005 neutralizing antibody combination protects against pertussis in murine and non-human primate models)

Analyst comments: INFN +4.6% (upgraded to Buy from Hold at Jefferies), FEYE +3.2% (upgraded to Buy from Neutral at UBS), MTRX +2.2% (upgraded to Buy from Hold at KeyBanc Capital Mkts), SGI +1.9% (upgraded to Buy at DA Davidson; tgt raised to $12), BAC +0.9% (upgraded to Buy from Neutral at Goldman), UBNT +0.9% (initiated with an Outperform at FBN Securities), TSLA +0.7% (initiated with an Outperform at FBN Securities), AIG +0.6% (initiated with a Buy at Citigroup)

Gapping down
In reaction to disappointing earnings/guidance: CPB -3.2%.

Select UK listed names showing weakness following sell-off in FTSE: LYG -4.7%, RBS -4.3%, GSK -3.7%, BCS -3.5%, AZN -2.4%, RDS.A -1.9%, HSBC -1.9%, BP -1.8%, SHPG -1.6%, RIO -1.5%, ING -1.3%

Other news: WRLD -7.7% (disclosed KPMG would not respond to recent request for proposal to serve as independent registered public accounting firm), DGLY -5.9% (cont volatility), AKS -3.4% (announces concurrent offerings of 35 mln shares common stock and senior unsecured notes with aggregate value of $430 mln), XON -2.9% (files mixed securities shelf offering), UEC -2.2% (files shelf offering for ~1.86 mln shares of common stock ), TKMR -1.7% (negative mention on Mad Money)

Analyst comments: KERX -6% (downgraded to Underperform at FBR Capital ), F -2.5% (downgraded to Underweight at Morgan Stanley), HMY -2.5% (initiated with a Neutral at JP Morgan), GOLD -1.6% (initiated with a Neutral at JP Morgan)

Оригинал статьи: gtstocks.com/analytics-08-09-2014.html

[gtcapital]

SPY понизился на премаркете

Ближайший уровень поддержки по SPY – 200.25 уровень сопротивления – 200.90



CMGE продажа от 28.50

MSI продажа от 61

Gapping up/down: BURL +6% and CASY +4% after earnings/guidance, BNNY and IPAS +37% on M&A news, BNNY peers trading higher, MZOR +7% on CFDA approval, THLD +15% on initiation; FRAN -12%, TITN -11%, and FCEL -10% after earnings, POT -1% after dg

Gapping up
In reaction to strong earnings/guidance: BURL +6.1%, CASY +4.1%, TPLM +3.4%, KFY +3%, HELI +2.2%, HDS +1.9%, CTLT +1.1%.

M&A news:BNNY +37.4% (to be acquired by General Mills (GIS) for $46 per share in cash), IPAS +36.8% (to explore strategic alternatives), GFIG +7.2% (BGC Partners (BGCP) announces intent to commence all cash tender offer to acquire GFI Group Shares for $5.25 Per Share).

Select BNNY peers showing strength: WWAV +5.5%, BDBD +4.5%, HAIN +3.8%.

Select Mad Money mentions trading higher: ATK +2%, NFLX +1.6%, LMT +1.1%, RTN +0.9%, SKX +0.5%.

Other news: MZOR +6.8% (receives China CFDA approval for its Renaissance Systems), IDTI +4.8% (working closely with Intel (INTC) on the development of wireless charging solutions), NVFY +3.8% (announces purchase order fulfilled with IKEA China), STKL +3.6% (will further expand its Modesto, California aseptic processing and packaging operation), GTAT +3.1% (ahead of Apple's product event — speculation as supplier), HSOL +2.6% (signs its second supply agreement with Baotou Shansheng New Energy for delivery of 50 MW of HSOL's PV modules), PRTS +2.2% (named Michael Yoshida Interim Chief Financial Officer; co has initiated a search for a new CFO), ABB +2.1% (announces $4 bln share repurchase), SGMS +1.9% (awarded three-year instant game contract extension with Colorado lottery), ADXS +1.5% (announces completion of an End-of-Phase 2 Meeting with the FDA for its lead Lm-LLO cancer immunotherapy), GLYC +1.1% (announced that data from preclinical studies demonstrating the in vivo efficacy of GMI-1051 will be presented), IMMR +1% (following late move higher on increased volume), MITK +1% (announced that it has agreed to end all pending litigation with Top Image Systems (TISA) andTIS America), JCP +1% (subsidiary commences underwritten public offering of $350 mln aggregate principal amount of senior unsecured notes), LPCN +0.9% (announces first patient dosed in Phase 1 study in pregnant women of LPCN 1107, potentially the first oral product for the prevention of preterm birth), AAPL +0.7% (trading higher in advance of product event).

Analyst comments: THLD +15% (initiated with a Buy at Cantor Fitzgerald), CTIC +9.7% (initiated with a Overweight at Piper Jaffray), ECYT +5.5% (initiated with a Buy at Cantor Fitzgerald), CEMP +4.2% (receives $10 mln milestone payment from Toyama Chemical Co), MACK +3.5% (initiated with a Buy at Cantor Fitzgerald ), MBLY +3.4% (hearing positive Morgan Stanley comments as catalyst), SYF +3.2% (initiated with a Overweight at JP Morgan and Morgan Stanley, among others), GCA +2.8% (upgraded to Buy at Stifel following MGAM purchase), LYG +2.3% (upgraded to Overweight from Neutral at HSBC Securities), MT +1.9% (upgraded to Outperform from Neutral at Credit Suisse), VRTU +1.7% (upgraded to Overweight from Neutral at JP Morgan), BCS +1.6% (upgraded to Overweight from Neutral at HSBC Securities), MDVN +1.4% (upgraded to Outperform from Mkt Perform at Bernstein), AMRI +1.3% (initiated with a Overweight at JP Morgan), DHI +1.2% (upgraded to Overweight from Neutral at JP Morgan)

Gapping down
In reaction to disappointing earnings/guidance: FRAN -11.7%, TITN -10.7%, FCEL -10.5%, PBY -7.1%, CNSI -5%, FUEL -2.4%, (announces CFO transition and reaffirms prior guidance for the 3Q14 and FY14 ), PTN -1%.

Other news: RADA -5.5% (following 130%+ surge higher following intraday earnings release), AVP -4.1% (announced resignation of CFO Kimberly Ross; Robert Loughran appointed acting CFO effective October 2, 2014), PF -3.7% (announced secondary offering of 15 mln shares of common stock by selling shareholders), DOC -2.6% (announced public offering of 9 mln shares of common stock; announces over $300 mln of commitments for new unsecured revolving credit facility), BKD -1.7% (prices public offering of 8,955,223 shares of Common Stock at $33.50/share), TNET -1.3% (announced commencement of secondary public offering of 10,500,000 shares by stockholders), AKS -1.3% (still checking), WBAI -0.9% (late weakness on cautious Muddy Waters mention).

Analyst comments: LUV -1.1% (initiated with a Neutral at Credit Suisse), POT -1% (downgraded to Underperform from Mkt Perform at Cowen), MOS -0.8% (downgraded to Sector Perform from Outperform at RBC Capital Mkts), JBLU -0.7% (initiated with a Underperform at Credit Suisse), CVX -0.7% (downgraded to Underperform from Neutral at BofA/Merrill).

Оригинал статьи: gtstocks.com/analytics-09-09-2014.html

[gtcapital]

SPY топчется на месте

Ближайший уровень поддержки по SPY – 199.25 уровень сопротивления – 199.75



THC продажа ниже 61

BITA покупка при удержании 82

NPSP продажа от 30

Gapping up/down: PANW +5% after earnings, CLF +2% on amended credit facility, TWTR +3% after upgrade; KKD -5% after earnings, AU -12% on restructuring announcement, GTAT -6% on dg at GS

Gapping up
In reaction to strong earnings/guidance: MNDL +10.2%, LMNR +8.1%, DIOD +6.8%, PANW +5.3%, LE +5%, UNIS +4.6%, PPHM +3.2%, PDLI +3.1%, SIRI +1.1%, IHT +1%, SAIC +0.5%.

M&A news: IMPV +2.8% (Imperva, TIBX, TDC among possible takeover targets by HP (HPQ), according to reports), EXPR +1.2% (Barron's mentions name as M&A target), FDO +0.3% (Dollar General (DG) commences cash tender offer to acquire FDO at $80 per share).

Select EU bell weather names showing strength: BP +1.7%, ING +1.2%, DB +0.9%, RDS.A +0.9%, ALU +0.6%.

Select Biotech stocks trading higher: MNOV +13.3%, NPSP +13% (following FDA briefing docs), TKMR +3.2%, SPPI +2.4%, ACHN +1%.

Other news: DRL +12.4% (announces the sale of ~$430 mln in assets), PVCT +7.5% (still checking), BDBD +6.8% (favorable commentary on Tuesday's Mad Money), SUPN +6.2% (Orchard Hill Capital Management files amended 13D; request that the Board hires a strategic advisor to consider selling the Company), BWEN +4.1% (announced $14 million in new tower orders from a U.S. wind turbine manufacturer), RADA +3.9% (cont momentum), SUNE +3.6% (Google (GOOG) executes $145 million investment in SunEdison and TerraForm Power's (TERP) largest solar plant in North America), GPRO +3% (still checking), CLF +1.8% (amended revolving credit facility to allow for $200 mln share repurchase program), FEYE +1.5% (in sympathy with PANW earnings), LTM +1.2% (favorable commentary on Tuesday's Mad Money), TFSL +1.1% (authorizes the purchase of up to 10,000,000 shares of the Company's outstanding common stock), THOR +1.1% (announced start of Heartmate III U.S. clinical trial) CRM +1% (signs agreement to establish new european data centre in France; selects Interxion (INXN) as service provider), HAIN +1% (favorable commentary on Tuesday's Mad Money), TSL +1% (to supply 70MW high efficiency modules to a large-scale solar power project in Chile), KFRC +1% (announces increase to board share buyback authorization by $70 mln).

Analyst comments: TWTR +2.7% (upgraded to Buy from Neutral at UBS), LB +0.9% (upgraded to Outperform from Neutral at Credit Suisse), COH +0.8% (upgraded to Overweight from Neutral at Atlantic Equities), TPLM +0.8% (upgraded to Buy from Accumulate at KLR Group)

Gapping down
In reaction to disappointing earnings/guidance: MGCD -9.7%, KKD -5.2%, URBN -2%, (Thus far during the third quarter of fiscal 2015, comparable Retail segment net sales are low single-digit negative), CBSO -1.8%, CRDS -1.7%, MANU -0.7%.

Other news: AU -11.9% (to explore the possibility of restructuring co into simpler and more focused entities), RSH -10.6% (cont weakness following Wedbush target cut to $0), AHH -5.7% (announces public offering of 5 mln shares of common stock), WBAI -5.4% (Muddy waters follow up from Value Walk), ACT -2.8% ( negative vote from the FDA's Cardiovascular and Renal Drugs Advisory Committee regarding NDA for nebivolol/valsartan for the treatment of hypertension), SCOK -2.8% (modestly pulling back after yesterday's advance), AVB -2.4% (announces offering of 4.5 mln shares of common stock), GFI -1.8% (may be in sympathy with AU), EQY -1.6% (announced 3.825 mln share public offering of common stock), STM -1.5% (potentially related to Apple (AAPL) event), TI -1.4% (América Movil (AMX) and Telefonica (TEF) among cos that are close to bid for Telecom Italia's (TI) Brazil operations, according to reports), ARMH -1.1% (potentially related to Apple (AAPL) event).

Analyst comments: GTAT -6.4% (downgraded to Neutral from Buy at Goldman), BYD -3.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley), MBLY -2.8% (downgraded to Hold from Buy at Deutsche Bank on valuation), EBAY -1.3% (downgraded to Neutral from Overweight at Piper Jaffray), SAVE -1.2% (downgraded to Mkt Perform from Outperform at Cowen), TIF -0.8% (downgraded to Neutral from Outperform at Credit Suisse), AAPL -0.6% (downgraded to Sector Perform from Outperform at Pacific Crest).

Оригинал статьи: gtstocks.com/analytics-10-09-2014.html

[gtcapital]

SPY падает на премаркете

Ближайший уровень поддержки по SPY – 199.00 уровень сопротивления – 199.70



LE продажа от 40

EMES покупка выше 130

SLCA покупка выше 70

UTHR продажа от 122

GPRO покупка выше 69

Gapping up/down: JDSU +14% after guidance/spin-off announcement, LULU +14% after earnings, GPRO +3% after gt raise; RH -4% after earnings, energy and metals tradind lower, CROX -3% after dg

Gapping up
In reaction to strong earnings/guidance: GRO +19.4%, JDSU +14%, (reaffirms; to Separate into Two Industry-Leading Public Companies), LULU +13.6%, SIGM +10%, LFVN +8%, WTSL +5.9%, MBUU +5.1%, BRC +3.1%, RSH +2.2%

M&A news: RAX +0.9% (cont M&A spec)

Other news: IMRS +19.7% (neurosurgical HFD rocker arm receives FDA clearance), DGLY +12.8% (to introduce 'Bullet Camera' option for FirstVU HD body camera system at IACP conference), LAND +7.7% (announces REIT Election), GOGO +5.4% (Gogo and T-Mobile (TMUS) to deliver free in-flight texting and voicemail to T-Mobile customers), RXII +4.5% (presented an update on the company's dermatology and ophthalmology franchises), PT +3.8% (still checking), FNSR +3.6% (following JDSU news/guidance), GPRO +3.3% (favorable commentary on Wednesday's Mad Money), SOL +2.1% (to supply 10MW DCR solar modules to Utility-Scale project in India), POWR +1.9% (disclosed it acquired the electrical contracting business of Apex Controls), MDVN +1.4% (FDA approves new indication for the use of XTANDI (enzalutamide) capsules for patients with metastatic castration-resistant prostate cancer), MBLY +1.4% (still checking), EXXI +1.2% (Energy XXI late spike attributed to speculation of Gulf of Mexico asset sale), GTAT +1.2% (modestly rebounding), EMC +1.2% (reports of VMW stake sale), TWX +0.9% (does not have plans for HBO spin off, 'seriously' looked at Fox (FOXA) offer, CEO said, according to reports)

Analyst comments: GPRO +3.3% (target raised to $70 from $42 at Citigroup), NES +2% (initiated with a Buy at Stifel), SEAS +1.5% (upgraded to Outperform from Neutral at Macquarie), PBR +1.3% (initiated with an Outperform at Cowen), TS +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), TCAP +0.7% (upgraded to Outperform from Market Perform at Wells Fargo), JLL +0.6% (upgraded to Overweight from Neutral at JP Morgan), GDP +0.6% (initiated with an Outperform at Cowen)

Gapping down
In reaction to disappointing earnings/guidance: EOPN -28.6%, (updates guidance; announces that three customers will not be renewing contracts; names new head of sales organization ), SYMX -22.9%, DLIA -13%, FIVE -5%, RH -3.8%

Select China related names showing weakness: CAAS -8.8%, CSUN -4.7%, CGA -4.5%, MY -4.5%, VIPS -2%

Select metals/mining stocks trading lower: HMY -2.6%, MT -1.4%, SLV -1.2%, FCX -1.2%, SLW -1.1%, GOLD -0.9%, GG -0.8%, ABX -0.7%

Select oil/gas related names showing early weakness: E -2.4%, RIG -1.6%, BHP -1.6%, SSL -1.6%, STO -1.3%, TOT -1.2%

Other news: INVE -17.4% (announces proposed stock offering ), ASTM -4.4% (announces pricing of public offering of 13,725,490 shares of Common Stock at $2.55/share), NETE -3.7% (following 100%+ move higher yesterday). NBR -3.6% (hearing Activist investor may be selling shares, according to article), TEF -1.9% (still checking), TWTR -1.6% (announces $650 mln convertible unsecured senior note offering; announces amendment to revolving credit agreement)

Analyst comments: CROX -3.7% (downgraded to Neutral from Buy at Buckingham Research), M -1.8% (downgraded to Neutral from Buy at Sterne Agee)

Оригинал статьи: gtstocks.com/analytics-11-09-2014.html

[gtcapital]

Снижение тарифов на торговом терминале Takion

Компания GT Capital Group рада сообщить вам о снижении тарифов для новых трейдеров на торговом терминале Takion. Так же сумма минимального депозита составляет всего 500$. Мы надеемся, что новые условия сделают для вас доступнее фондовый рынок США.

Ознакомиться с новыми тарифами можно здесь: http://gtstocks.com/treyder.html

В ближайшие недели у нас будет еще несколько нововведений которые должны порадовать трейдеров.

Стоимость торгового терминала Takion может быть уменьшена по согласованию с менеджером.

[gtcapital]

SPY отыграл гэп вниз на премаркете

Ближайший уровень поддержки по SPY – 198.60 уровень сопротивления – 199.10

:

AVB покупка от 145

SLG покупка выше 104

VNG смотрим на покупку

Gapping up/down: TWGP +12% on M&A approval, spirit related names also higher on M&A spec in the space, NOK +2% on upgrade; TEX -8% after guidance, RAX -4% after dg

Gapping up
M&A news: TWGP +11.7% (ACP Re announced that ACP Re has received all regulatory approvals required in connection with its previously announced acquisition of Tower), CTSH +2.8% (to acquire TriZetto for $2.7 bln in cash), WHR +2.1% (receives written approval from the China Securities Regulatory Commission to acquire a 51% stake in Hefei Rongshida Sanyo Electric), VC +1.1% (may be a possible takeover target, Bloomberg real M&A column says)

Other news: RSH +17.6% (considering $585 mln financing package, also Hearing Suntrust analyst suggesting reasoning behind potential Amazon (AMZN) deal), OTIV +13.2% (extending last weeks gains), TAP +7.2% (in response to M&A stories in the space), HALO +5.9% (partner Baxter (BAX) receives FDA approval from HYQVIA for treatment of adults with primary immunodeficiency), AU +5.5% (Hearing speculation that company will not proceed with restructuring), BPOP +3.8% (positive Barrons mention), ATHM +3.6% (favorable commentary on Friday's Mad Money, Tiger Global Management discloses 18.5% passive stake), BUD +3.1% (in financing talks for SABMiller deal), MYL +2.5% (Mylan Labs signs agreement with Gilead (GILD) to accelerate access to hepatitis C treatments), BITA +2.5% (Tiger Global Management discloses 14.9% passive stake), TGTX +2.5% (announces special protocol assessment agreement with the FDA for its first phase 3 clinical trial of TG-1101), DEO +2.2% (in response to M&A stories in the space), TASR +2% (Columbus and Knoxville join major cities moving to AXON cameras and EVIDENCE.com; new body-worn camera programs launch in Argentina and United Arab Emirates), YHOO +1.8% (Alibaba (BABA) may increase IPO range amid high demand to above $70 from $60-66 prior, according to reports), MO +1.8% (co has a 26.9% voting interest in Sabmiller (SBMRY))

Analyst comments: WGO +5.2% (initiated with an Outperform at BMO Capital Mkts), PAY +1.8% (initiated with a Buy at Monness Crespi & Hardt), NOK +1.7% (upgraded to Outperform at Oppenheimer), AYI +1.6% (upgraded to Buy from Neutral at Goldman), ABX +0.9% (upgraded to Neutral from Underweight at HSBC Securities)

Gapping down
In reaction to disappointing earnings/guidance: TEX -7.8%

Select oil/gas related names showing early weakness: E -1.2%, SDRL -1%, TOT -1%, BP -0.7%

Other news: NPSP -14.0% (FDA Advisory Committee votes 8-5 the recommend approval of Natpara), NETE -7% (pulling back following Friday's advance), ACHN -3% (still checking), INSY -2.9% (disclosed it received a subpoena requesting documents regarding Subsys), ALXN -1.8% (reports 5 yr results of Asfotase Alfa in ped patients with severe HPP), WB -1.5% (still checking), BHP -0.8% (weak industrial production figures out of China), DE -0.6% (in sympathy with TEX), CAT -0.5% (in sympathy with TEX)

Analyst comments: RAX -3.9% (downgraded to Neutral from Overweight at JP Morgan), TSLA -2.2% (weakness attributed to Morgan Stanley analyst comments, suggesting stock may be a bit ahead of itself), PKD -1.6% (downgraded to Equal Weight from Overweight at a boutique firm), PLOW -1.2% (downgraded to Neutral from Outperform at Robert W. Baird), UBS -1.2% (downgraded to Equal Weight from Overweight at Barclays), TRP -1% (downgraded to Sell from Neutral at Goldman), CLW -0.7% (downgraded to Neutral at DA Davidson)

Оригинал статьи: gtstocks.com/analytics-15-09-2014.html

[gtcapital]

SPY консолидируется на премаркете

Ближайший уровень поддержки по SPY – 198.65 уровень сопротивления – 198.90



AVNR продажа ниже 12

CAB покупка на продолжение тренда вверх

YY покупка при удержании 80

WDAY покупка выше 86

UBNT покупка выше 43

Gapping up/down: SODA +4% on M&A related news, VNET +4%, AEO +2% and DATA +2% on upgrades/initiations; ALOG -3.5% after earnings, Casino names trading lower, ACI -2% after dg

Gapping up
In reaction to strong earnings/guidance: SINO +33.1%, (surged higher into the close after reporting earnings in late trade), FONR +9.2%, AXR +3.5%

M&A news: SODA +4.2% (in discussions with British fund regarding sale, according to reports)

Other news: RWLK +5.9% (cont momentum following IPO), PSTI +5.9% (pursues development strategy in Japan where new law accelerates path to market), SSH +5.5% (to provide clinical updates from the North American feasibility study), UEC +5% (reports positive preliminary economic assessment on Anderson Project in Arizona), OREX +3.9% (after seeing notable late move off lows on insider buy disclosures), AXAS +2.3% (raises Q3 production guidance to 6.9-7.0 Boepd, up from 6.5-6.7 Boepd), JDSU +1.9% (favorable commentary on Monday's Mad Money), CSIQ +1.1% (announces 1.5 MW solar module supply agreement in Jordan), YNDX +1.1% (modest rebound after yesterday's decline)

Analyst comments: DRYS +5.2% (initiated with a Buy at Deutsche Bank), VNET +4.4% (upgraded to Outperform from Sector Perform at Pacific Crest), STRI +4.1% (upgraded to Buy at Craig Hallum), GASS +3.5% (initiated with a Buy at Deutsche Bank), AEO +2% (upgraded to Overweight from Equal Weight at a boutique firm), DATA +1.8% (upgraded to Outperform from Neutral at Credit Suisse), DSX +1.4% (initiated with a Buy at Deutsche Bank), TNK +1.3% (initiated with a Buy at Deutsche Bank), TAP +1.3% (initiated with an Outperform at Cowen), CPLP +1% (initiated with a Buy at Deutsche Bank), TEX +0.9% (upgraded to Buy at Stifel)

Gapping down
In reaction to disappointing earnings/guidance: COOL -13.7%, (thinly traded), FULL -4.7%, ALOG -3.5%, PARN -2.5%

M&A news: AT -18.9% (provides update on outcome of strategic review process; sale or merger of co not in best interests of co or its stakeholders at this time), BUD -1.6% (WSJ says Anheuser-Busch InBev seeking financing for SABMiller plc (SBMRY) deal), ORAN -1.4% (Group will launch a friendly voluntary cash tender offer for the acquisition of 100% of the capital of Jazztel)

Select EU heavy-weight names showing weakness: ALU -1.5%, AZN -1.4%, BCS -1.1%, ARMH -0.8%, DB -0.7%, LYG -0.6%

Select Casino stocks trading lower: MGM -3%, LVS -2.4%, WYNN -1.8%, CNTY -1.5%, BYD -0.9%

Other news: SIGA -27.1% (files for Chapter 11 reorganization), PIP -15.9% (still checking), OPXA -10.2% (announces proposed public offering of common stock), OXPA -10.2% (still checking), GST -7.9% (announced that it intends to offer 17 mln shares of its common stock ), AVNR -6.7% (modest pull back following yesterdays 80%+ advance), CHA -3.2% (Shanghai -1.8% overnight), CHL -2.9% (Shanghai -1.8% overnight), ACI -2.1% (China plans to ban low grade coal, according to reports), NFLX -1.8% (FCC to consider net neutrality for mobile broadband, according to reports), BTU -1.2% (China plans to ban low grade coal, according to reports), GPRO -1.1% (cont pre-mkt vol), AA -1% (announces proposed public offering of 25 mln depository share of Mandatory Convertible Preferred Stock)

Analyst comments: ACI -2.1% (downgraded to Reduce from Neutral at Nomura), CMI -1.2% (downgraded to Market Perform from Outperform at Wells Fargo), BTU -1.2% (downgraded to Reduce from Neutral at Nomura), SAP -1.1% (initiated with a Sector Perform at RBC Capital Mkts), YOKU -0.8% (hearing cautious OTR mention), OXY -0.6% (downgraded to Equal Weight from Overweight at Barclays), ADBE -0.6% (assumed with a Sector Perform (down from Outperform) at RBC Capital Mkts)

Оригинал статьи: gtstocks.com/analytics-16-09-2014.html

[gtcapital]

Ближайший уровень поддержки по SPY – 200.25 уровень сопротивления – 200.65



HUM продажа от 132.50

LCA продажа ниже 71

GILD продажа от 105

DLPH покупка от 67.20

VXX покупка от 27.80

Оригинал статьи: gtstocks.com/analytics-17-09-2014.html

[gtcapital]

Мы рады сообщить вам о новом тарифе «Старт» для тех кто только хочет начать торговать на фондовой бирже США. До нового сезона отчетов, осталось всего пару недель и вы успеете попробовать свои силы в самый активный период времени на рынке, когда профессиональные трейдеры зарабатывают больше всего денег. Не упустите свой шанс!

Условия акции:

Для депозитов от 500 до 1000$ комиссия будет всего 0,6$ за 100 акций. Для депозитов больше 1000$ комиссия 0,4$ за 100 акций. Акция проходит на торговой платформе Fusion и не распространяется на другие торговые терминалы. Срок проведения акции до 1 октября. Акция действуйте, только на новые счета.

Успейте открыть счет и торгуйте на выгодных условиях!

Оригинал статьи: http://gtstocks.com/tariffstart2014.html

[gtcapital]

Ближайший уровень поддержки по SPY – 200.50 уровень сопротивления – 201.65



FDX продажа от 160

DRC смотрим на продажу

ALNY продажа от 78

X продажа от 46

DD покупка при удержании 69.50

KSU продажа ниже 122

SKX покупка от 59

CPA покупка при удержании 113, ниже продажа

Gapping up/down: STLD +5% and CAG +3% after earnings/guidance, EMKR +45% after sale of Space Photovoltaics biz, KSS +1% after upgrade; PIR -13% and RAD -7% after earnings, DNR -2% after dg

Gapping up
In reaction to strong earnings/guidance: PWE +8.1%, ROSG +5.4%, STLD +4.6%, MLHR +3.4%, CAG +2.8%, UNFI +2%, CLC +1.6%

M&A news: SODA +3.1% (story making the rounds suggesting M&A from DEO, KKR or SBMRY), SNN +1.9% (renewed M&A spec post Stryker (SYK) analyst meeting), WWAV +1.8% (acquires So Delicious Dairy Free for ~$195 mln in cash)

Other news: EMKR +45.7% (announces the sale of its Space Photovoltaics Business to Veritas Capital, announces CEO transition plan), BAXS +20% (to explore strategic alternatives for its MIS Spine Business), XXII +18.7% (enters cannabis space; acquires exclusive U.S. license to Cannabinoid Biosynthesis Genes and takes 25% stake in biotechnology company), VVUS +17.8% (Vivus and Auxilium (AUXL) announce FDA approval of STENDRA sNDA), WYY +8.4% (subsidiary iSYS receives task order from U.S. Citizenship and Immigration Services), RSH +8.2% (cont pre-mkt vol), CGEN +4.2% (still checking), GILT +3.3% (still checking), SONS +3.3% (board of directors voted to terminate the co's shareholder rights plan effective Sep 17, 2014), MOBI +3.2% (announces strategic partnership with China Telecom (CHA)), ERIC +3.2% (announced it will discontinue future development of modems and shift parts of resources in modems to radio network R&D ), NETE +3% (CEO Oleg Firer discloses 6.5% stake), STM +1.9% (may be moving with ERIC), A +1.8% (transition of CEO: Mike McMullen to succeed Bill Sullivan in March 2015; creates new group for services and consumables), CY +1.7% (favorable commentary on Wednesday's Mad Money), ISIS +1.7% (favorable commentary on Wednesday's Mad Money), YHOO +1.2% (cont momentum ahead of BABA IPO), X +0.9% (in sympathy with STLD), OVTI +0.8% (Hua Capital Management hired bankers to fund possible OVTI bid, according to reports), INFY +0.6% (announced a global partnerships with Huawei, MSFT, and Hitachi for various products/svcs), AAPL +0.6% (iPhone 6 has received 1 China license, according to reports)

Analyst comments: IOC +4.1% (initiated with a Outperform at Credit Suisse), TKMR +2.4% (positive commentary at Maxim), VNCE +1.6% (initiated with a Buy at B. Riley & Co), KSS +1.3% (upgraded to Buy from Neutral at Citigroup), RYI +1.1% (initiated with a Buy at KeyBanc Capital Mkts), MON +1% (upgraded to Buy at Stifel), MT +0.8% (upgraded to Buy from Neutral at BofA/Merrill), DD +0.7% (upgraded to Overweight from Neutral at JP Morgan), BXP +0.6% (upgraded to Buy at Stifel), BA +0.5% (added to Franchise Pick list at Jefferies)

Gapping down
In reaction to disappointing earnings/guidance: PIR -12.8%, MCHX -10.9%, RAD -7.5%, CLR -1.4%, GDOT -0.7%


Other news: ECTE -4.9% (Therapeutics Platinum seeks return of $5 mln investment in Echo Therapeutics), SNE -4.8% (cont weakness following Japan session (guided downward yest)), AVNR -1.5% (cont volatility after the the large move this week), ENDP -0.8% (pulling back modestly following yesterday's merger annoncement of AUXL), VNET -0.5% (posted its second response to short seller, rejects the baseless allegations)

Analyst comments: DNR -2.1% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)

Оригинал статьи: http://gtstocks.com/analytics-18-09-2014.html

[gtcapital]

Ближайший уровень поддержки по SPY – 201.25 уровень сопротивления – 201.75



Сегодня крупнейшее IPO компании Alibaba (тикер BABA). Подробнее можно почитать тут: gtstocks.com/forum/viewtopic.php?f=38&t=31&p=61#p61

CPA покупка выше 77.50

CRR смотрим на откат после гэпа

Gapping up/down: CNQR +19% after merger with SAP (-4%), YHOO +2% ahead of BABA IPO, GLNG +4% after upgrade; TIBX, VMI, and ORCL -3% after earnings, ESI -15% following Wells Notice, CRR -6% after dg at GS Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: PDEX +28.6%

M&A news: CNQR +19.4% (to be acquired by SAP subsidiary, SAP America, for $129 per share), DRC +12.1% (following reports that company may receive $80/share bid from Siemens (SI)), LULU +1.6% (Keybanc discussed VFC exec comments suggesting possible LULU deal)

Select Apple value chain related names showing strength: RFMD +1.3%, SWKS +1%, AVGO +0.8%, NXPI +0.7%

Select China related names showing strength ahead of BABA IPO: WB +1.7%, JD +1.1%, BIDU +0.8%

Other news: NAVB +10.5% (confirms it received Orphan Drug Designation from FDA for Use of Lymphoseek in Head and Neck Cancers), MCP +5.3% (Oaktree Capital Mgmt discloses 9.1% stake in 13G), HIMX +4.2% (climbed higher into the close after analyst suggested Google may replace Samsung OLED displays with Himax), JBLU +4.2% (announced that Robin Hayes, the company's current President, will succeed Dave Barger as CEO, effective February 16, 2015), INVN +3.4% (reports indicate that iPhone 6 contains InvenSense MP67B 6-axis Gyroscope), EMES +2.6% (initiated with a Buy at Goldman), MGA +2.5% (announces cooperation regarding regulatory investigation), SHLD +2.3% (Fairholme Capital Management disclosed 24% active stake in 13D filing), RBS +2.1% (following result of Scottish referendum), YHOO +1.9% (trading higher in advance of BABA IPO, also target raised to $48 from $44 at Piper Jaffray, tgt raised to $43 from $39 at Cantor Fitzgerald), WEN +1.7% (Trian Fund Management reports 24.39% stake in amended 13/D filing), RAD +1.5% (favorable commentary on Thursday's Mad Money), AMD +1.3% (co and Synopsys expanded their IP partnership), GILD +1.2% (announces European Commission granted marketing authorization for co's Zydelig), VOD +0.8% (in relation to Vivendi (VIVHY) authorized agreement with Telefonica (TEF) concerning the acquisition of GVT), GSK +0.8% (announces China investigation outcome; will pay a fine of GBP297 mln), HTZ +0.8% (China Partner, CAR Inc. announces IPO), NFLX +0.5% (officially launches in France, Germany, Austria, Switzerland, Belgium And Luxembourg)

Analyst comments: GLNG +4.5% (target raised to $110 from $75 at BofA/Merrill), FRAN +2.6% (upgraded to Buy from Neutral at Buckingham Research), AEO +2.4% (upgraded to Buy from Neutral at Goldman), NVAX +2.2% (assumed with an Outperform at Wedbush), ZION +1.2% (upgraded to Strong Buy from Outperform at Raymond James), VFC +1% (upgraded to Buy from Hold at KeyBanc Capital Mkts), FEYE +1% (target raised to $40 from $36 at Piper Jaffray), AMZN +0.8% (target raised to $435 at RBC Capital Mkts)

Gapping down
In reaction to disappointing earnings/guidance: TIBX -3.6%, VMI -3.2%, ORCL -2.8%, (also appoints Larry Ellison Executive Chairman and CTO; Larry Ellison steps down as CEO )

M&A news: SAP -4.1% (acquiring CNQR for $129 per share)

Select metals/mining names showing weakness: GFI -1.6%, RIO -1.5%, MT -1.3%, HMY -1.2%, IAG -0.9%, BHP -0.7%

Other news: ESI -15% (disclosed it received Wells Notice), QRHC -14% (announced proposed public offering), EROC -4.5% (filed for ~53.34 mln unit offering of common units representing limited partner interests by selling unitholders), STM -3.9% (still checking), CLDT -3.1% (launched public offering of 5 mln common shares), BXMT -2.7% (announces public offering of class A common stock), SNE -2.2% (continued weakness following guiding earlier this week), GLUU -1.9% (filed for ~9.98 mln share common stock offering by selling shareholders), TOT -1.5% (received offer from Arkema (ARKAY) to acquire its Bostik affiliate; offer values Bostik at EUR1.74 bln), MITK -0.8% (disclosed Chief Marketing Officer, Scott Carter, is leaving the co)

Analyst comments: CRR -6.3% (downgraded to Sell from Neutral at Goldman), AUXL -4% (downgraded to Neutral from Buy at Goldman), SDRL -1.2% (downgraded to Underperform from Neutral at Exane BNP Paribas)

Оригинал статьи: gtstocks.com/analytics-19-09-2014.html

[gtcapital]

Ближайший уровень поддержки по SPY – 195.00 уровень сопротивления – 196.00



LRCX продажа от 75

WLP покупка от 119

DWRE продажа ниже 58

Gapping up/down: SIMO +15% and CAMP +7% after earnings, FEYE +6% after new partnerships; GMCR +2% on upgrade at GS; SODA and TCS -15% after earnings/guidance; LVS -3% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: SIMO +14.9%, CAMP +7.2%, ISCA +4.9%, NLNK +1.9%, IDT +0.6%

Select Ebola related names showing strength: CMRX +3.9%, TKMR +3.4%, LAKE +2.8%

Select metals/mining stocks trading higher: IGLD +2.5%, IAG +0.8%, CDE +0.8%, SVM +0.6%

Other news: GTAT +15% (modest retracement following yesterday's massive decline), MAGS +15% (receives $8.2 mln of new orders; majority of the contracts are for expansions, changes and upgrades of existing homeland security installations in Israel), XCO +10.6% (announces sale of interests in Compass Production Partners), BCLI +9% (FDA grants fast track designation to NurOwn for the treatment of ALS), OXGN +8.3% (announced that data from the Phase 2 GOG186I study of fosbretabulin in combination with bevacizumab will be presented on November 9 at the International Gynecologic Cancer Society), GSAT +7.1% (issues statement in response to Kerrisdale Capital presentation), FEYE +5.8% (FireEye and SingTel partner to launch first managed defense solution; also, announced targeted attack protection for the Apple (AAPL) platform), BCRX +2.4% (announces late breaker presentation of OPuS-1 Phase 2 Trial results at the 23rd EADV Congress will be present Oct 11), ADHD +2.3% (after yesterday's 57% decline), ACHN +1.8% (disclosed it entered into a Master Security Agreement for a $1,000,000 Capital Expenditure Line of Credit), SBLK +1.6% (collected $8.016 mln from the sale of its claim against PAN OCEAN), REGN +1.3% (EYLEA (aflibercept) Injection received FDA approval for macular edema following retinal vein occlusion), PSTI +1.3% (wins cell therapy patent case in Europe; European Patent Office confirms validity of amended claims )

Analyst comments: ADHD +2.3% (upgraded to Outperform at FBR Capital), NDLS +2.1% (upgraded to Buy from Hold at Jefferies), AUY +2.1% (upgraded to Neutral from Underweight at HSBC Securities), GMCR +1.9% (initiated with a Buy at Goldman), KPTI +1.1% (initiated with a Outperform at Wedbush), IP +1.1% (upgraded to Buy from Neutral at BofA/Merrill), CCK +0.7% (upgraded to Outperform from Neutral at Macquarie)

Gapping down
In reaction to disappointing earnings/guidance: SODA -15.1%, TCS -14.6%, EZPW -13.6%, CBK -11.8%, AEGN -9.3%, AGCO -8.7%

M&A news: RIO -1% (issues statement regarding press speculation surrounding Glencore (GLNCY))

Notable EU names showing weakness: ORAN -2.2%, DB -2.1%, NOK -2%, NBG -1.8%, RCL -1.2%, CCL -1.1%, AZN -1.1%, UBS -1.1%, LYG -0.8%, CS -0.8%

Other news: KOS -6.1% (announces secondary public offering of 15 mln common shares), BBEP -5.3% (announces public offering of 14 mln common units), END -5.3% (announced the appointment of a Chief Restructuring Officer), IBIO -4.7% (files for sale of up to 23,418,172 shares of common stock by Aspire Capital Fund), CNHI -4.3% (in sympathy with AGCO earnings), KCAP -3.8% (commences 3 mln share public offering), DYN -2.1% (launched 22.5 mln share common stock and 4 mln share mandatory convertible preferred stock offerings), NRP -2% (prices 8.5 mln common units at $12.02 per common unit), OTIV -1.6% (filed for $50 mln mixed securities shelf offering), BUD -1.6% (still checking), MBLY -1.4% (cont weakness), NUS -1% (following afternoon strength on volume)

Analyst comments: LVS -3.1% (downgraded to Hold from Buy at Deutsche Bank), URI -2.7% (downgraded to Neutral from Buy at BofA/Merrill), DE -2.6% (downgraded to Underperform from Neutral at BofA/Merrill), SAN -1.4% (downgraded to Reduce from Neutral at Nomura), CMI -1.3% (downgraded to Neutral from Buy at BofA/Merrill), ATI -1.2% (downgraded to Hold from Buy at KeyBanc Capital Mkts), USB -0.8% (downgraded to Mkt Perform from Strong Buy at Raymond James )

Оригинал статьи: gtstocks.com/analytics-07-10-2014.html